Was the SOPH CEO’s share sale under a Rule 10b5-1 trading plan?

Yes. The filing states the sales were executed under a pre-established Rule 10b5-1(c) trading plan adopted by the reporting person. This plan-based structure indicates the transactions were pre-arranged and are described as not representing discretionary trades.

CEO’s tax-driven share sale at SOPHiA GENETICS (SOPH) detailed

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

SOPHiA GENETICS SA Chief Executive Officer Jurgi Camblong reported an open-market sale of 4,486 Ordinary Shares. The shares were sold on April 20, 2026 at a weighted average price of $5.205 per share, in multiple trades ranging from $5.08 to $5.29.

The sale was made to satisfy tax withholding obligations arising from restricted stock units that vested on April 18, 2026, under a pre-established Rule 10b5-1(c) trading plan and is described as non-discretionary. After the transaction, Camblong directly holds 3,642,481 Ordinary Shares.

Insider Trade Summary 10b5-1

Net Seller: 4,486 shares ($23,350)

Net Sell 1 txn

Insider Camblong Jurgi

Role Chief Executive Officer

Sold 4,486 shs ($23K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	4,486	$5.205	$23K

Holdings After Transaction: Ordinary Shares — 3,642,481 shares (Direct, null)

Footnotes (1)

Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.08 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 4,486 shares Weighted average sale price: $5.205 per share Post-transaction holdings: 3,642,481 shares +1 more

4 metrics

Shares sold 4,486 shares Ordinary Shares sold on April 20, 2026

Weighted average sale price $5.205 per share Open-market sale price, multiple transactions

Post-transaction holdings 3,642,481 shares Ordinary Shares directly held after sale

Sale price range $5.08–$5.29 per share Range of individual trade prices reported

Key Terms

restricted stock units, Rule 10b5-1(c) trading plan, tax withholding obligations, weighted average price

4 terms

restricted stock units financial

"arising in connection with the vesting of restricted stock units on April 18, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Rule 10b5-1(c) trading plan regulatory

"These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan"

A Rule 10b5-1(c) trading plan is a legally defined, pre-set schedule that lets company insiders automatically buy or sell stock at specified times or under set formulas when they are not in possession of undisclosed, sensitive information. Think of it like an automatic payment plan for trades: because the instructions are written in advance, trades under the plan help protect insiders from allegations of trading on secret information and give investors clearer expectations about when insiders will transact, which can affect liquidity and perceived transparency.

tax withholding obligations financial

"sold by the Reporting Person in the open market to satisfy tax withholding obligations"

weighted average price financial

"The price reported in Column 4 is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Form 4 Insider Transactions: What Each Field Means →

04/21/2026 - 04:04 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Camblong Jurgi

(Last)

(First)

(Middle)

C/O SOPHIA GENETICS SA

LA PIECE 12

(Street)

ROLLE

1180

(City)

(State)

(Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
SOPHiA GENETICS SA [ SOPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	04/20/2026		S		4,486⁽¹⁾	D	$5.205⁽²⁾	3,642,481	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.08 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Elimara Brunetto as Attorney-in- Fact for Jurgi Camblong	04/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did SOPH CEO Jurgi Camblong report?

Jurgi Camblong reported selling 4,486 SOPHiA GENETICS Ordinary Shares in the open market at a weighted average price of $5.205 on April 20, 2026. The trades occurred between $5.08 and $5.29 per share.

Why did SOPH CEO sell 4,486 shares of SOPHiA GENETICS stock?

The shares were sold to cover tax withholding obligations from restricted stock units that vested on April 18, 2026. The filing notes these tax-related sales followed a pre-established Rule 10b5-1(c) trading plan and were not discretionary trades.

How many SOPHiA GENETICS shares does the CEO hold after this Form 4?

Following the reported sale, CEO Jurgi Camblong directly holds 3,642,481 Ordinary Shares of SOPHiA GENETICS SA. This indicates the 4,486 shares sold represent a small fraction of his total reported direct holdings after the transaction.

At what prices were the SOPH shares sold by the CEO?

The reported weighted average sale price was $5.205 per share. According to the footnote, individual trades occurred in multiple transactions at prices ranging from $5.08 to $5.29 per share, with full trade-by-trade details available upon written request.

Does this SOPHiA GENETICS Form 4 involve any derivative securities?

No derivative transactions are listed in the summarized data. The reported activity involves only non-derivative Ordinary Shares, and the derivative position summary is empty, indicating no option or other derivative exercises in this particular Form 4.